Strategic Partnerships Roche actively collaborates with external biotech firms (e.g., CARsgen Therapeutics) to evaluate combo therapies, indicating a fertile avenue for channel partners, CROs, and alliances that expand Roche’s clinical programs and diagnostics integration.

Digital & Cloud Readiness The tech stack includes Cloudflare, OneTrust, Gatsby and other modern tools suggesting Roche prioritizes scalable, secure digital platforms. This opens upsell opportunities for cybersecurity, data privacy, cloud optimization, and digital health solution integrations.

Innovative Diagnostics Recent launches include automated mass spectrometry-based clinical analyzers and Cobas SARS-CoV-2 tests, signaling continued investment in high-throughput diagnostics and point-of-care technologies suitable for lab automation vendors and service expansions.

Breast Cancer Portfolio PHESGO and established Herceptin/Perjeta lines show a strong oncology franchise with subcutaneous delivery options, presenting cross-sell potential for companion diagnostics, patient management tools, and hospital enabling technologies.

Global Expansion With a multinational footprint and leadership in India diagnostics via senior HR movements, there is momentum for region-specific supply chain enhancements, regulatory consulting, and localized support services to accelerate market penetration.